Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fuhr

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
American Health & Drug Benefits|July 4, 2014
The economics of biosimilarsErwin A Blackstone, P Fuhr Joseph
The New England Journal of Medicine|July 17, 1986
The comparative economic performance of investor-owned and not-for-profit hospitalsE A Blackstone, J P Fuhr
Journal of Medical Systems|August 1, 1989
Exclusive arrangements in the hospital industryE A Blackstone, J P Fuhr
Journal of Health Law|August 28, 2003
Failed hospital mergersErwin A Blackstone, Joseph P Fuhr
Future Medicinal Chemistry|March 25, 2011
Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticalsErwin A Blackstone, Joseph P Fuhr
Muscle & Nerve|June 1, 1992
Cutaneous reflexes in Parkinson's diseaseP Fuhr, T Zeffiro, M Hallett
Biotechnology Healthcare|February 12, 2013
Generic biopharmaceutical drugs: an economic and policy analysisErwin A Blackstone, Joseph P Fuhr
Journal of Health Politics, Policy and Law|December 29, 1998
Rural hospital mergers, antitrust policy, and the Ukiah caseE A Blackstone, J P Fuhr
Biotechnology Healthcare|April 6, 2012
Biopharmaceuticals: the economic equationErwin A Blackstone, Joseph P Fuhr
Journal of Health Law|May 2, 2000
Hospital mergers: the shift from federal antitrust enforcement to state regulationE A Blackstone, J P Fuhr
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
American Health & Drug Benefits|July 4, 2014
The economics of biosimilarsErwin A Blackstone, P Fuhr Joseph
The New England Journal of Medicine|July 17, 1986
The comparative economic performance of investor-owned and not-for-profit hospitalsE A Blackstone, J P Fuhr
Journal of Medical Systems|August 1, 1989
Exclusive arrangements in the hospital industryE A Blackstone, J P Fuhr
Journal of Health Law|August 28, 2003
Failed hospital mergersErwin A Blackstone, Joseph P Fuhr
Future Medicinal Chemistry|March 25, 2011
Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticalsErwin A Blackstone, Joseph P Fuhr
Muscle & Nerve|June 1, 1992
Cutaneous reflexes in Parkinson's diseaseP Fuhr, T Zeffiro, M Hallett
Biotechnology Healthcare|February 12, 2013
Generic biopharmaceutical drugs: an economic and policy analysisErwin A Blackstone, Joseph P Fuhr
Journal of Health Politics, Policy and Law|December 29, 1998
Rural hospital mergers, antitrust policy, and the Ukiah caseE A Blackstone, J P Fuhr
Biotechnology Healthcare|April 6, 2012
Biopharmaceuticals: the economic equationErwin A Blackstone, Joseph P Fuhr
Journal of Health Law|May 2, 2000
Hospital mergers: the shift from federal antitrust enforcement to state regulationE A Blackstone, J P Fuhr
Pageof 11